BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 17390054)

  • 21. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.
    Silverberg MJ; Abrams DI
    Curr Opin Oncol; 2007 Sep; 19(5):446-51. PubMed ID: 17762569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update: cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy.
    Grulich AE
    AIDS Read; 2000 Jun; 10(6):341-6. PubMed ID: 10881365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
    Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
    J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
    Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of acquired immunodeficiency syndrome malignancies.
    Goedert JJ
    Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS-Related Malignancies.
    Wool GM
    Oncologist; 1998; 3(4):279-283. PubMed ID: 10388117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High incidence of non-AIDS-defined cancers among HIV-infected patients in Germany. A 3-year nationwide review].
    Mosthaf FA; Hanhoff NJ; Goetzenich A; Wolf E; Knechten H
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1849-52. PubMed ID: 16915544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The oncology impact of highly active antiretroviral therapy.
    Schlichemeyer R; Chambers C; Gill MJ
    J Oncol Pharm Pract; 2007 Mar; 13(1):17-25. PubMed ID: 17621563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIDS and associated malignancies.
    Wood C; Harrington W
    Cell Res; 2005; 15(11-12):947-52. PubMed ID: 16354573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
    Cinti SK; Gandhi T; Riddell J
    AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten years later: a single hospital experience with malignancy in HIV/AIDS.
    Reed M; Cosgrove JM; Cindrich R; Parithivel VS; Gad Y; Bangalore M; Uzor R; Kalim J; Segura R; Albu E
    J Surg Oncol; 2010 Sep; 102(3):282-6. PubMed ID: 20740588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS-associated malignancies.
    Akanmu AS
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():57-70. PubMed ID: 18050776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C; Lee S; Wong Kh; Cheng L; Lam M
    HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy.
    Palmieri C; Treibel T; Large O; Bower M
    QJM; 2006 Dec; 99(12):811-26. PubMed ID: 17085516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumour effects of antiretroviral therapy.
    Monini P; Sgadari C; Toschi E; Barillari G; Ensoli B
    Nat Rev Cancer; 2004 Nov; 4(11):861-75. PubMed ID: 15516959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer incidence in AIDS patients in Catalonia, Spain.
    Galceran J; Marcos-Gragera R; Soler M; Romaguera A; Ameijide A; Izquierdo A; Borràs J; de Sanjosé S; Casabona J
    Eur J Cancer; 2007 Apr; 43(6):1085-91. PubMed ID: 17349785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.